CIA
AXDX icon

Cape Investment Advisory’s Accelerate Diagnostics AXDX Stock Holding History

Cape Investment Advisory’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-300
Closed -$1.18K – 945
2023
Q4 		$1.18K Buy
+300
New +$1.59K ﹤0.01% 994

Other funds holding AXDX

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cannell & Spears
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TCI Wealth Advisors
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cape Investment Advisory's AXDX Position: Q1 2024 in Review

Cape Investment Advisory sold out of Accelerate Diagnostics (AXDX) in Q1 2024, closing a stake of 300 shares — an estimated $1.18K sold.

Cape Investment Advisory first reported a position in AXDX in Q4 2023 and held it in 1 quarter. The position peaked at $1.18K in Q4 2023. 46 funds tracked by Wall St. Rank hold AXDX as of Q1 2024.

  • Cape Investment Advisory reported no remaining Accelerate Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Cape Investment Advisory sold 300 Accelerate Diagnostics shares in Q1 2024, an estimated $1.18K.
  • Cape Investment Advisory first reported a position in Accelerate Diagnostics in Q4 2023 and held it in 1 quarter.
  • Cape Investment Advisory's Accelerate Diagnostics position peaked at $1.18K in Q4 2023.
  • 46 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2024.

Based on Cape Investment Advisory's 13F filing for Q1 2024, filed 21 Jun 2024.